- All
- Acute kidney injury
- aHUS
- Alport syndrome
- Anaemia
- Andy Cole Fund
- BK virus
- Blog
- Blood pressure
- Calciphylaxis
- Cancer
- Case study
- Chronic kidney disease
- CMV
- Collaboration and partnerships
- Coronavirus
- Corporate partnership
- cystinosis
- Cystinuria
- Diabetes
- Dialysis
- Focal segmental glomerulosclerosis
- Fundraising
- Health Equalities
- Heart disease
- HUS
- Idiopathic nephrotic syndrome
- IgA nephropathy
- Kidney health
- Kidney stones
- Lupus
- Mental health
- Nephrotic syndrome
- NURTuRE
- Paediatric
- Patient Stories
- Podcast
- Policy
- Polycystic kidney disease
- Research
- Transplantation
- Uncategorised
- Volunteering

Looking after your kidney health over the festive period
For many people, a highlight of the festive season and something to look forward to, is celebrating with family over a special meal, a works office party with colleagues, or Christmas drinks with friends. For people living with kidney disease, Christmas can be a very different experience and needs some extra planning. We’re sharing some…

SGLT2-inhibitors: a new era in protecting kidney health?
A type of medication called SGLT2 inhibitors could help people with chronic kidney disease (CKD) stay well for longer. We spoke to our funded researcher, consultant nephrologist Dr Dominic Taylor from the University of Bristol to hear more about SGLT2 inhibitors and his study into getting access to this new treatment. Related links Taking control…

Parliamentary Launch of Rare Kidney Diseases Report at House of Commons Roundtable
This week, we hosted the parliamentary launch of our new report on rare kidney diseases at a high-profile roundtable event in the House of Commons. House of Commons Roundtable The event was hosted by Stuart Andrew MP, Shadow Secretary of State for Health and Social Care, and brought together key voices from patient and clinical…

Vote for the Make Your Mark campaign film in the Smiley Charity Film Awards
We’re excited to share that the short film ‘Is it inside you to save a life?’ from the Make Your Mark campaign, as part of the Robert Dangoor Partnership for Living Kidney Donation, has been entered for the Smiley Charity Film Awards 2026, helping to shine a spotlight on the life-saving impact of living kidney…

SMC approval of mercaptamine offers new hope and choice for people living with cystinosis in Scotland
In a landmark decision, the Scottish Medicines Consortium (SMC) has today (10 November) accepted a new treatment – mercaptamine (brand name Procysbi) – for people in Scotland living with cystinosis, a rare disease affecting about one in every 100,000 to 200,000 newborn babies. The decision marks a pivotal moment for people – mainly children and young…





